NYSE - Nasdaq Real Time Price USD

Cencora, Inc. (COR)

241.04 +3.09 (+1.30%)
As of 1:00 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
271,579,412.00
262,173,411.00
238,587,006.00
213,988,843.00
189,893,926.00
Cost of Revenue
262,297,060.00
253,213,918.00
230,290,639.00
207,045,615.00
184,702,042.00
Gross Profit
9,282,352.00
8,959,493.00
8,296,367.00
6,943,228.00
5,191,884.00
Operating Expense
6,480,370.00
6,273,888.00
5,542,857.00
4,099,423.00
3,158,279.00
Operating Income
2,801,982.00
2,685,605.00
2,753,510.00
2,843,805.00
2,033,605.00
Net Non Operating Interest Income Expense
-223,479.00
-228,931.00
-210,673.00
-174,074.00
-137,883.00
Other Income Expense
-227,724.00
-295,838.00
-359,780.00
-447,872.00
-7,189,553.00
Pretax Income
2,350,779.00
2,160,836.00
2,183,057.00
2,221,859.00
-5,293,831.00
Tax Provision
491,365.00
428,260.00
516,517.00
677,251.00
-1,894,273.00
Net Income Common Stockholders
1,867,048.00
1,745,293.00
1,698,820.00
1,539,932.00
-3,408,716.00
Diluted NI Available to Com Stockholders
1,867,048.00
1,745,293.00
1,698,820.00
1,539,932.00
-3,408,716.00
Basic EPS
9.28
8.62
8.15
7.48
-16.65
Diluted EPS
9.18
8.53
8.04
7.39
-16.65
Basic Average Shares
201,523.25
202,511.00
208,472.00
205,919.00
204,783.00
Diluted Average Shares
203,468.50
204,591.00
211,210.00
208,465.00
204,783.00
Total Operating Income as Reported
2,530,463.00
2,340,731.00
2,366,378.00
2,354,197.00
-5,135,354.00
Total Expenses
268,777,430.00
259,487,806.00
235,833,496.00
211,145,038.00
187,860,321.00
Net Income from Continuing & Discontinued Operation
1,867,048.00
1,745,293.00
1,698,820.00
1,539,932.00
-3,408,716.00
Normalized Income
2,081,813.50
2,021,881.95
1,994,201.72
1,880,209.56
1,207,992.03
Interest Income
49,981.00
46,719.00
21,309.00
8,470.00
20,639.00
Interest Expense
273,460.00
275,650.00
231,982.00
174,074.00
137,883.00
Net Interest Income
-223,479.00
-228,931.00
-210,673.00
-174,074.00
-137,883.00
EBIT
2,624,239.00
2,436,486.00
2,415,039.00
2,395,933.00
-5,155,948.00
EBITDA
3,708,120.00
3,417,334.00
3,124,874.00
2,910,719.00
-4,747,935.00
Reconciled Cost of Revenue
262,275,746.00
253,196,974.00
230,274,699.00
207,036,001.00
184,685,091.00
Reconciled Depreciation
1,083,881.00
980,848.00
709,835.00
514,786.00
408,013.00
Net Income from Continuing Operation Net Minority Interest
1,867,048.00
1,745,293.00
1,698,820.00
1,539,932.00
-3,408,716.00
Total Unusual Items Excluding Goodwill
-271,519.00
-344,874.00
-387,132.00
-489,608.00
-7,191,134.00
Total Unusual Items
-271,519.00
-344,874.00
-387,132.00
-489,608.00
-7,191,134.00
Normalized EBITDA
3,979,639.00
3,762,208.00
3,512,006.00
3,400,327.00
2,443,199.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-56,753.50
-68,285.05
-91,750.28
-149,330.44
-2,574,425.97
9/30/2020 - 4/4/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MCK McKesson Corporation
541.01
+1.04%
 
CAH Cardinal Health, Inc.
104.37
+0.80%
 
HSIC Henry Schein, Inc.
72.80
-0.56%
 
PDCO Patterson Companies, Inc.
25.76
-1.60%
 
OMI Owens & Minor, Inc.
24.13
-2.47%
 
ZYXI Zynex, Inc.
11.03
-1.78%
 
MCK.DU McKesson Corp
500.20
+0.66%
 
MCK.F McKesson Corporation
497.10
+0.04%
 
UPR.IR Uniphar plc
2.5100
-3.83%